share_log

鲁抗医药(600789.SH):目前产品结构和主营业务均未发生重大变化

Shandong Lukang Pharmaceutical (600789.SH): Currently, there have been no significant changes in the product structure and main Business.

Gelonghui Finance ·  Jan 6 03:44

Gelonghui reported on January 6 that Shandong Lukang Pharmaceutical (600789.SH) announced that on January 2, January 3, and January 6, 2025, the cumulative deviation of the closing price increase of the company's stocks exceeded 20% within a continuous period of two trading days. According to the relevant provisions of the "Shanghai Stock Exchange Trading Rules," this constitutes abnormal fluctuations in stock trading. The company's main business includes the research and development, production, and sales of pharmaceutical products. The company's products mainly involve anti-infection drugs, cardiovascular drugs, digestive system drugs, endocrine drugs, urological drugs, respiratory system drugs, and veterinary agricultural antibiotics. Currently, there have been no significant changes in the product structure and main business.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment